☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+: The US FDA New Drug Approvals in February 2022
March 17, 2022
BioIntelliSense Launches BioButton Rechargeable Wearable Device for Continuous Monitoring of 20+ Vital Signs and Biometrics
March 17, 2022
Prestige BioPharma Publishes the Results of Tuznue (biosimilar, trastuzumab) in the JAMA Oncology
March 17, 2022
Perrigo’s Nasonex 24HR Allergy Receives the US FDA’s Approval for Nasal Allergy Spray
March 17, 2022
AbbVie’s Rinvoq Receives the US FDA’s Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
March 17, 2022
Apellis Reports Results of Pegcetacoplan in P-III (DERBY and OAKS) Studies for Geographic Atrophy (GA)
March 17, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions